HIRSCHMAN ORIN 13D and 13G filings for Abeona Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-10 4:59 pm Sale | 2022-12-31 | 13G | Abeona Therapeutics Inc. ABEO | HIRSCHMAN ORIN | 652,174 3.800% | -139,644 (-17.64%) | Filing |
| 2022-11-04 10:52 am Purchase | 2022-11-03 | 13G | Abeona Therapeutics Inc. ABEO | HIRSCHMAN ORIN | 791,818 6.100% | 791,818 (New Position) | Filing |